CSPC Pharmaceutical Group Limited
CHJTF
$1.28
$0.0756.25%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.26B | 1.25B | 1.54B | 1.49B | 1.91B |
| Total Receivables | -- | 1.32B | -- | 1.68B | -- |
| Inventory | -- | 428.82M | -- | 475.96M | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | 3.00B | -- | 3.64B | -- |
|
|
|||||
| Total Current Assets | -- | 3.00B | -- | 3.64B | -- |
| Net Property, Plant & Equipment | -- | 1.71B | -- | 1.60B | -- |
| Long-term Investments | -- | 32.18M | -- | 32.33M | -- |
| Goodwill | -- | 32.18M | -- | 32.33M | -- |
| Total Other Intangibles | -- | 344.93M | -- | 308.25M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 133.49M | -- | 120.19M | -- |
| Total Assets | -- | 6.08B | -- | 6.59B | -- |
|
|
|||||
| Total Accounts Payable | -- | 409.43M | -- | 444.55M | -- |
| Total Accrued Expenses | -- | 523.55M | -- | 1.14M | -- |
| Short-term Debt | -- | 49.90M | -- | 27.87M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 11.92M | -- | 16.51M | -- |
| Total Finance Division Other Current Liabilities | -- | 325.09M | -- | 945.93M | -- |
| Total Other Current Liabilities | -- | 325.09M | -- | 945.93M | -- |
| Total Current Liabilities | -- | 1.32B | -- | 1.44B | -- |
|
|
|||||
| Total Current Liabilities | -- | 1.32B | -- | 1.44B | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 49.90M | -- | 27.87M | -- |
| Capital Leases | -- | 7.69M | -- | 9.13M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 114.06M | -- | 126.93M | -- |
| Total Liabilities | -- | 1.44B | -- | 1.57B | -- |
|
|
|||||
| Common Stock & APIC | -- | 1.59B | -- | 1.58B | -- |
| Retained Earnings | -- | 3.51B | -- | 3.75B | -- |
| Treasury Stock & Other | -- | -685.90M | -- | -538.58M | -- |
| Total Common Equity | 4.45B | 4.42B | 4.97B | 4.80B | 4.60B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.45B | 4.42B | 4.97B | 4.80B | 4.60B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | 219.42M | -- | 223.12M | -- |
| Total Equity | 4.67B | 4.64B | 5.20B | 5.02B | 4.85B |
|
|
|||||